Join to view full profile
9055 E Del Camino DrSte 100Scottsdale, AZ 85258
Phone+1 480-860-5000
Dr. Tsai is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
Stony Brook Medicine/University HospitalResidency, Internal Medicine, 2002 - 2005
Stony Brook University Health Sciences Center School of MedicineClass of 2002
Certifications & Licensure
AZ State Medical License 2012 - 2028
CO State Medical License 2013 - 2015
NY State Medical License 2005 - 2013
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2016-2017
- CMS Meaningful Use Stage 1 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2016-2017
Clinical Trials
- A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer Start of enrollment: 2015 Apr 29
Publications & Presentations
PubMed
- A phase II clinical trial of albumin-bound paclitaxel, cisplatin, gemcitabine (NABPLAGEM), and paricalcitol as neoadjuvant therapy in pancreatic cancer.Alexa F Viniotis, Gayle S Jameson, Betsy C Wertheim, Denise J Roe, Keehoon Lee
The Oncologist. 2026-06-06 - 1 citationsPhase 1 Study of INBRX-105, a TNFRSF9 (4-1BB) and PD-L1 Bispecific Antibody, in Patients with Select Solid Tumors.Jong Chul Park, David Berz, Manish R Sharma, Jyoti Malhotra, Anthony W Tolcher
Cancer Research Communications. 2026-02-01 - 3 citationsImmersive Virtual Reality for Enabling Patient Experience and Enrollment in Oncology Clinical Trials: A Feasibility Study.Frank Tsai, Landon Gray, Amy Mirabella, Margaux Steinbach, Jacqueline M Garrick
Cancers. 2025-03-29
Press Mentions
Immersive Experiences Could Help Educate Patients, Cut down on Video Call FatigueJune 11th, 2020
First Cancer Patient Receives Dose of Super-Enhancer Inhibitor GZ17-6.02, an Advanced Cancer Drug from Genzada Pharmaceuticals, at HonorHealth Research InstituteMarch 20th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: